MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 591 SEK -1.17% Market Closed
Market Cap: 8.8B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

Net Margin
MedCap AB (publ)

12.7%
Current
11%
Average
0.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.7%
=
Net Income
227.9m
/
Revenue
1.8B

Net Margin Across Competitors

Country SE
Market Cap 8.8B SEK
Net Margin
13%
Country US
Market Cap 1.2T USD
Net Margin
9%
Country US
Market Cap 200.4B USD
Net Margin
14%
Country US
Market Cap 165.4B USD
Net Margin
18%
Country KR
Market Cap 66.8T KRW
Net Margin
24%
Country CH
Market Cap 38.4B CHF
Net Margin
9%
Country US
Market Cap 38.5B USD
Net Margin
20%
Country US
Market Cap 35.9B USD
Net Margin
9%
Country US
Market Cap 26.8B USD
Net Margin
21%
Country US
Market Cap 24.1B USD
Net Margin
17%
Country CN
Market Cap 164.4B CNY
Net Margin
21%
No Stocks Found

MedCap AB (publ)
Glance View

Market Cap
8.8B SEK
Industry
Life Sciences Tools & Services

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

MCAP Intrinsic Value
486.21 SEK
Overvaluation 18%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.7%
=
Net Income
227.9m
/
Revenue
1.8B
What is the Net Margin of MedCap AB (publ)?

Based on MedCap AB (publ)'s most recent financial statements, the company has Net Margin of 12.7%.